Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 1 Minute to 6 Months

Investigating brain blood flow and elasticity in newborns using ultrasound techniques

Official title: Contrast Enhanced Ultrasound and Elastography of the Neonatal Brain

Run by Turku University Hospital · NCT05648812 · Data updated 2026-11-12

This study is testing a safe ultrasound method to see how blood flows and how stretchy the brain tissue is in newborns, especially those with certain health issues.

Quick facts

PhasePhase 3
Study typeInterventional
Ages1 Minute to 6 Months
SexAll
Enrollment100 (estimated)
SponsorTurku University Hospital
Government
Drugs / interventionsradiation
Locations1 site (Turku, Southwestern Finland)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedJuly 2029
Study endsDecember 2029
Registry record updatedJanuary 15, 2026
Trial IDNCT05648812 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include infants under 7 months old treated at the neonatal units of Turku University Hospital.

Probably not a fit

Patients with known genetic diseases, severe congenital malformations, or unstable cardiovascular conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess brain perfusion and tissue elasticity in neonates adapting to life outside the womb, particularly those with conditions like hypoxic ischemic encephalopathy and stroke. Utilizing contrast-enhanced ultrasound with sulphur hexafluoride and ultrasound-assisted elastography, the research will provide insights into cerebral hemodynamics. The study will recruit a total of 100 infants from the Neonatal Units of Turku University Hospital over a potential seven-year period. The ultrasound examinations will be performed without radiation or sedation, making it a safe approach for this vulnerable population.

Why it matters

Potential benefit: If successful, this study could enhance the diagnostic capabilities for neonatal brain conditions, leading to better management and outcomes for affected infants.

How similar studies have gone: While the use of ultrasound techniques in neonates is established, this specific combination of contrast-enhanced ultrasound and elastography for assessing brain conditions is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Babies less than 7 months treated at the neonatal units of Turku University hospital

Exclusion Criteria:

* Pre-known genetic disease
* Difficult congenital malformations that need surgical treatment
* Central nervous system tumors
* Weight less than 2,5 kg during examination
* Medical history of SonoVue hypersensitivity
* Uncontrolled systemic hypertension
* Systolic pulmonary artery pressure \> 90 mmHg
* Unstable cardiovascular state

Where it's running

  • Turku University Hospital
    Turku, Southwestern Finland, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.